Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by DexterMorganon Jul 26, 2014 4:30pm
143 Views
Post# 22784799

RE:Yup!

RE:Yup!This company desparately needs a "new start" with a new team that can take it to the next level, replace the current core team (and buy out their positions) that is responsible for undermining the integrity of this company.  Fundamentally, the trust required by investors to encourage investment to the organic growth of the company does not exist and is solely attributed to lack of faith amongst the current team that is responsible for the stench associated with this group.  The company does have legs on the basis of the core science but the associated business core team and associated stock players (pump and dump) needs to be painfully addressed in order for anything to have legs to move forward.
We need a new team to clean out the old blood, focus on cleaning up the current stock structure which, as most know, should lead to a rollback .  This should not present an issue for anyone provided the science can back it up which, based on what we have seen and read, there is something here.  
Perhaps the best thing would be for SBM to sell their asset, provide the relief to the team at TFChem and move onto better ventures suited to the current players like......medical marijuana, gold, platinum, lithium, uranium......take your pick, I dont think it really matters to the current pump and dump team.  
Bullboard Posts